Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse
Status:
Completed
Trial end date:
2016-11-18
Target enrollment:
Participant gender:
Summary
The purpose of this two part study is to test the safety and efficacy of Tafenoquine (with
Cholorquine) as a radical cure for Plasmodium vivax (P.vivax) malaria relative to the control
Chloroquine.Part 1 aims to select an efficacious and well tolerated dose that can be
co-administered with Chloroquine. Part 2 will investigate the safety and efficacy of the
selected dose (300 mg tafenoquine) in the treatment and radical cure of Plasmodium Vivax
Malaria.